ARCHIVES

FDA Approves Lilly’s Alimta For Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

Backing Down On Forward Funding? HHS Now Says It Won’t Make Multiple Year Awards Until September

April 5, 1985

House Members Urge FDA to Review Fast Track Policies

July 5, 2002

DCT Board Approves Drug Development Recompetition

November 30, 1990

RFAs For Extramural Construction, Mouse Facility Available

March 2, 1990

NTP Board Okays Contract Concepts

July 10, 1981

Capitol Hill: Senate bill would allow sale of therapies for catastrophic illness after phase I trials.

December 2, 2005